Affordable Access

Publisher Website

Randomized, controlled trial of phytoestrogen in the prophylactic treatment of menstrual migraine

Authors
Journal
Biomedicine & Pharmacotherapy
0753-3322
Publisher
Elsevier
Publication Date
Volume
56
Issue
6
Identifiers
DOI: 10.1016/s0753-3322(02)00181-6
Keywords
  • Phytoestrogen
  • Menstrual Migraine
  • Migraine Prophylaxis
Disciplines
  • Medicine

Abstract

Abstract Approximately 30% of women afflicted with migraine have menstrually associated attacks. These migraines are often refractory to treatment. Evidence suggests estrogen and progestin fluctuations may influence menstrual migraine. Phytoestrogens have demonstrated estrogenic effects in some tissues, but are without stimulation of the endometrium, suggesting decreased risk with long-term use. This study was undertaken to assess the efficacy of a phytoestrogen combination in the prophylactic treatment of menstrual migraine. Forty-nine patients were randomized to receive either placebo, or a daily combination of 60 mg soy isoflavones, 100 mg dong quai, and 50 mg black cohosh, with each component standardized to its primary alkaloid. Patients received study medication for 24 weeks. Average frequency of menstrually associated migraine attacks during weeks 9–24 was reduced from 10.3 ± 2.4 (mean ± s.e.m.) in placebo treated patients to 4.7 ± 1.8 ( P < 0.01) in patients treated with the phytoestrogen preparation.

There are no comments yet on this publication. Be the first to share your thoughts.